You are here

iTeos Therapeutics

TIGIT drug from iTeos shrinks lung tumors in trial

BioPharma Dive

Sun, 09/15/24 - 06:28 pm

iTeos Therapeutics

Iteos – and GSK – keep the faith

EP Vantage

Tue, 05/9/23 - 10:40 am

iTeos Therapeutics

Licensing deals rack up in 2021

EP Vantage

Fri, 12/10/21 - 10:46 am

iTeos Therapeutics

Bristol Myers Squibb

GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race

Fierce Biotech

Mon, 06/14/21 - 10:17 am

iTeos Therapeutics

immuno-oncology

iTeos busts out early human data for anti-TIGIT antibody. Is it enough to match up with Roche, Merck?

Endpoints

Sun, 04/11/21 - 11:48 pm

iTeos Therapeutics

Roche move endorses Iteos’s Tigit widget

EP Vantage

Tue, 03/3/20 - 10:52 am

Arcus Biosciences

iTeos Therapeutics

Next-Gen Cancer Immunotherapy Company Banks $75 Million Oversubscribed Series B Round

CP Wire

Wed, 06/20/18 - 11:25 am

iTeos Therapeutics

Next-Gen Cancer Immunotherapy Company Banks $75 Million Oversubscribed Series B Round

Wed, 06/20/18 - 11:25 am

iTeos Therapeutics

In surprise move, Pfizer hands back IDO1 inhibitor

Biopharma Dive

Sat, 01/6/18 - 12:29 pm

iTeos Therapeutics